Hongzhou Lu
Impact in
- Infectious Diseases top 0.2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Modeling and Simulation top 0.5%
- COVID-19 epidemiological studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 26
- COVID-19 Clinical Research Studies 24
- HIV/AIDS Research and Interventions 10
- Tuberculosis Research and Epidemiology 10
- Epidemiology 62
- Influenza Virus Research Studies 16
- Fungal Infections and Studies 12
- Co-authors
- Yi‐Wei Tang (8 shared papers)Charles W. Stratton (1 shared paper)Yun Ling (14 shared papers)Yuxin Shi (4 shared papers)Fei Shan (4 shared papers)Fengxiang Song (2 shared papers)Nannan Shi (2 shared papers)Jie Shen (2 shared papers)
- Journals
- BioScience Trends (23 papers)Drug Discoveries & Therapeutics (8 papers)Medicine (5 papers)Frontiers in Cellular and Infection Microbiology (3 papers)Emerging Microbes & Infections (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Hongzhou Lu
178 papers receiving 6.5k citations
Hongzhou Lu's Hit Papers
Peers
Comparison fields: 5 of 185
- Infectious Diseases 3.0k
- Modeling and Simulation 507
- Neurology 724
- General Dentistry 74
- Virology 154
Countries citing papers authored by Hongzhou Lu
This map shows the geographic impact of Hongzhou Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongzhou Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongzhou Lu more than expected).
Fields of papers citing papers by Hongzhou Lu
This network shows the impact of papers produced by Hongzhou Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongzhou Lu. The network helps show where Hongzhou Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Hongzhou Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 189 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle Hit paper breakdown → | 2020 | 2295 |
| 2 | Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia Hit paper breakdown → | 2020 | 887 |
| 3 | 2020 | 495 | |
| 4 | Clinical Features of the Initial Cases of 2009 Pandemic Influenza A (H1N1) Virus Infection in China Hit paper breakdown → | 2009 | 464 |
| 5 | 2020 | 198 | |
| 6 | 2007 | 172 | |
| 7 | 2020 | 142 | |
| 8 | 2019 | 142 | |
| 9 | 2002 | 107 | |
| 10 | 2016 | 98 | |
| 11 | 2004 | 62 | |
| 12 | 2017 | 52 | |
| 13 | 2020 | 48 | |
| 14 | 2021 | 47 | |
| 15 | 2018 | 43 | |
| 16 | 2020 | 41 | |
| 17 | 2020 | 41 | |
| 18 | 2022 | 36 | |
| 19 | 2010 | 36 | |
| 20 | 2002 | 35 |
About Hongzhou Lu
Hongzhou Lu is a scholar working on Infectious Diseases, Epidemiology, Virology, Molecular Biology and Emergency Medicine, having authored 189 papers that have together received 6.7k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (26 papers), COVID-19 Clinical Research Studies (24 papers), Influenza Virus Research Studies (16 papers), Fungal Infections and Studies (12 papers), HIV Research and Treatment (12 papers), HIV/AIDS Research and Interventions (10 papers), Tuberculosis Research and Epidemiology (10 papers) and HIV-related health complications and treatments (10 papers). The work is most often cited by research in Infectious Diseases (3.0k citations), Modeling and Simulation (507 citations), Neurology (724 citations), General Dentistry (74 citations) and Virology (154 citations). Hongzhou Lu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yi‐Wei Tang, Charles W. Stratton, Yun Ling, Yuxin Shi, Fei Shan, Fengxiang Song, Nannan Shi, Jie Shen, Zhiyong Zhang and Yebin Jiang. Their work appears in journals such as BioScience Trends, Drug Discoveries & Therapeutics, Medicine, Frontiers in Cellular and Infection Microbiology and Emerging Microbes & Infections.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.